Key Facts

Invested since 2017
Based in Bavaria

About the company

PreOmics develops and provides innovative technologies for customers around the world for mass spectrometry (MS) – based proteomics using cutting-edge technologies to support researchers in their protein analysis needs.

Do you want to

know more about this company?

PreOmics in the news

preomics logo Zum Artikel

News

18. January 2022

PreOmics Announces Early Investors’ Exit and Closing of Series B Financing to Accelerate R&D and Commercialization of Proteomics Tools and Consumables

Zum Artikel

News

18. December 2018

High-Tech Gründerfonds and Think.Health Ventures together with Business Angels invest 3.3 million euros in a series A for the growth of PreOmics in Martinsried, Germany

More startups from Life Sciences